InvestorsHub Logo
icon url

chmcnfunds

04/28/11 4:18 PM

#1150 RE: califax #1149

Great news. Positive trend which was begun earlier today has continued after market. Some must have had information from the meeting.
Now up 6.2%.

Love the highlighted points.
Quote:
_________________________________________________________________

Additional highlights from Dr. Goldfarb''s presentation on Zerenex are as follows:

* Statistically significant dose response increase in serum bicarbonate suggests potential to address metabolic acidosis
* Statistically significant dose response reduction in calcium x phosphorus product
* Modest upward trends in Ferritin and TSAT in 6 grams/day and 8 grams/day dose groups further supports theory that Zerenex could reduce the need for intravenous iron and erythropoiesis-stimulating agent (ESA) use
* Zerenex appeared to be safe and well-tolerated in the study
* GI adverse events were mostly mild and transient in nature
* No SAEs were deemed to be drug-related by the Data Safety Monitoring Committee
____________________________________________________________________
http://www.prnewswire.com/news-releases/keryx-biopharmaceuticals-announces-positive-final-data-from-zerenex-short-term-phase-3-study-120887829.html

KERX